Rockwell Medical (NASDAQ: RMTI) reported Q4 EPS of $0.02, $0.07 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $18.3 million versus the consensus estimate of $16.53 million.

For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.